Enrique Grande Pulido

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet · 2017 · 175 citations · Full text

Platinum-based Therapy, Urology, Metastatic Urothelial Carcinoma +8

Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy

M. Blanco, Angélica Figueroa, Enrique Grande Pulido et al. · International Journal of Endocrinology · 2010 · 174 citations · Full text

Drug Targeting, Sugar Carrier Expression, Medicine +14

Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study

Yohann Loriot, Jonathan E. Rosenberg, Tom Powles et al. · Annals of Oncology · 2016 · 24 citations

Urology, Genitourinary Cancer, Advanced/metastatic Urothelial Carcinoma +6

PAZONET: Results of a phase II trial of pazopanib as a sequencing treatment in progressive metastatic neuroendocrine tumors (NETs) patients (pts), on behalf of the Spanish task force for NETs (GETNE)—NCT01280201.

Enrique Grande Pulido, Daniel Castellano, Rocio García‐Carbonero et al. · Journal of Clinical Oncology · 2012 · 17 citations

Previous Mtor Inhibitors, Pathology, Pharmacotherapy +19

Old and New Insights in the Treatment of Thyroid Carcinoma

Joan Manel Gasent Blesa, Enrique Grande Pulido, Mariano Provencio et al. · Journal of Thyroid Research · 2010 · 14 citations · Full text

Tumor Biology, Thyroid Carcinoma, Medicine +15